Here are four stocks with buy ranks and strong momentum characteristics for investors to consider today, October 31 st :
Acacia Communications, Inc. (ACIA): This provider of high-speed coherent interconnect products carries a Zacks Rank #1 (Strong Buy), as the Zacks Consensus Estimate for its current year earnings has advanced 6.1% over the last 30 days.
ACACIA COMMUNIC Price and Consensus
Acacia Communications' year-to-date return is a whopping 130.2%. The company possess a Momentum Score of A.
ACACIA COMMUNIC Price
Allison Transmission Holdings, Inc. (ALSN): This manufacturer of commercial and defense fully-automatic transmissions for medium- and heavy-duty commercial vehicles has seen the Zacks Consensus Estimate for its current year earnings soaring 5.1% over the last 30 days. As a result, it holds a Zacks Rank #1.
ALLISON TRANSMN Price and Consensus
Allison Transmission's year-to-date return is 13.3%. The company possess a Momentum Score of B.
ALLISON TRANSMN Price
Arch Capital Group Ltd. (ACGL): This provider of property, casualty, and mortgage insurance and reinsurance products has seen the Zacks Consensus Estimate for its current year earnings increasing 2.6% over the last 30 days. As a result, it carries a Zacks Rank #2 (Buy).
ARCH CAP GP LTD Price and Consensus
Arch Capital's year-to-date return is 11.1%, compared with the S&P 500's return of 4.2%. The company possess a Momentum Score of A.
ARCH CAP GP LTD Price
Ariad Pharmaceuticals Inc. (ARIA): this oncology company holds a Zacks Rank #2, as the Zacks Consensus Estimate for its current year earnings has surged 21.6% over the last 30 days.
ARIAD PHARMA Price and Consensus
Ariad Pharmaceuticals' year-to-date return is 40.5%. The company carries a Momentum Score of A.
ARIAD PHARMA Price
Learn more about the Momentum score and how it is calculated here
Want to see all of today's Zacks Strong Buys?
You are welcome to download the full, up-to-the-minute list of 220 Zacks Rank #1 stocks free of charge. There is no better place to start your own stock search. Plus you can also access the full list of must-avoid Zacks Strong Sells and other private research. See the stocks free >> .
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.